The resultant increase in KIF4A drives LSCC cell proliferation and migration while inhibiting apoptosis; conversely, KIF4A knockdown mitigates the pro-tumour effects of ERCC6L overexpression [101]. The gene discussed is KIF4A; the disease is neoplasm.